Emma L. Stephenson
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Emma L. Stephenson has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- Peter Braude
King’s College London, St. Thomas’ Hospital
2 shared publications - Chris Mason
The Advanced Centre for Biochemical Engineering, University College London, Torrington Place, London, WC1E 6BT, UK
1 shared publication - Dusko Ilic
King’s College London
1 shared publication Laureen Jacquet
Guy’s and St. Thomas Hospital NHS Foundation Trust
1 shared publicationOlga Genbacev
University of California San Francisco, The Eli and Edythe Broad Center for Regeneration Medicine and Stem Cell Research
1 shared publicationSusan J. Fisher
University of California San Francisco, The Eli and Edythe Broad Center for Regeneration Medicine and Stem Cell Research
1 shared publication
Latest Publications
- 2 October 2013
- Published by Springer Nature
- p. 153-164
PGD and Human Embryonic Stem Cell Technology
- 23 February 2010
- Published by Springer Nature in In Vitro Cellular & Developmental Biology - Animal
- Vol. 46 (3) , 178-185
Derivation of the King’s College London human embryonic stem cell lines
Since the derivation of the first human embryonic stem cell (hESC) line in 1998, there has been substantial interest in the potential of these cells for regenerative medicine and cell therapy and in the use of hESCs carrying clinically relevant genetic mutations as models for disease research and therapeutic target identification. There is still a need to improve derivation efficiency and further the understanding of the basic biology of these cells and to develop clinical grade culture systems with the aim of producing cell lines suitable for subsequent manipulation for therapy. The derivation of initial hESC lines at King’s College London is discussed here, with focus on derivation methodology. Each of the derivations was distinctive. Although the stage and morphology of each blastocyst were generally similar in each attempt, the behaviour of the colonies was unpredictable; colony morphology and development was different with each attempt. Days 5, 6 and 7 blastocysts were used successfully, and the number of days until appearance of stem-like cells varied from 4 to 14 d. Routine characterisation analyses were performed on three lines, all of which displayed appropriate marker expression and survived cryopreservation—thaw cycles. From the lines discussed, four are at various stages of the deposition process with the UKSCB, one is pending submission and two are unsuitable for banking. Continued open and transparent reporting of results and collaborations will maximise the efficiency of derivation and facilitate the development of standardised protocols for the derivation and early culture of hESC lines.
- 23 February 2010
- Published by Springer Nature in In Vitro Cellular & Developmental Biology - Animal
- Vol. 46 (3) , 178-185
Derivation of the King’s College London human embryonic stem cell lines
Since the derivation of the first human embryonic stem cell (hESC) line in 1998, there has been substantial interest in the potential of these cells for regenerative medicine and cell therapy and in the use of hESCs carrying clinically relevant genetic mutations as models for disease research and therapeutic target identification. There is still a need to improve derivation efficiency and further the understanding of the basic biology of these cells and to develop clinical grade culture systems with the aim of producing cell lines suitable for subsequent manipulation for therapy. The derivation of initial hESC lines at King’s College London is discussed here, with focus on derivation methodology. Each of the derivations was distinctive. Although the stage and morphology of each blastocyst were generally similar in each attempt, the behaviour of the colonies was unpredictable; colony morphology and development was different with each attempt. Days 5, 6 and 7 blastocysts were used successfully, and the number of days until appearance of stem-like cells varied from 4 to 14 d. Routine characterisation analyses were performed on three lines, all of which displayed appropriate marker expression and survived cryopreservation—thaw cycles. From the lines discussed, four are at various stages of the deposition process with the UKSCB, one is pending submission and two are unsuitable for banking. Continued open and transparent reporting of results and collaborations will maximise the efficiency of derivation and facilitate the development of standardised protocols for the derivation and early culture of hESC lines.
- 1 November 2006
- Published by Taylor & Francis in Regenerative Medicine
- Vol. 1 (6) , 739-750
Proposal for a universal minimum information convention for the reporting on the derivation of human embryonic stem cell lines
- 1 November 2006
- Published by Taylor & Francis in Regenerative Medicine
- Vol. 1 (6) , 739-750
Proposal for a universal minimum information convention for the reporting on the derivation of human embryonic stem cell lines